Navigation Links
Antiviral lipid earns patent
Date:3/5/2013

Dennis Voelker, PhD, professor of medicine at National Jewish Health, has been awarded a U.S. patent (#8,367,643) for various lipids and related compounds that can inhibit inflammation and infection in the lungs, especially those caused by influenza and respiratory syncytial virus (RSV). Over the past several years, Dr. Voelker has published several scientific papers describing a naturally occurring lipid in the lungs, POPG (palmitoyl-oleoyl-phosphatidylglycerol), that reduces inflammation and inhibits infection by the influenza virus and RSV. The patent covers POPG and other naturally occurring lipids in the lungs as well as related anionic lipids.

"POPG and related compounds offer a promising approach for the prevention and treatment of influenza and other respiratory virus infections," said Dr. Voelker. "We are thrilled to earn this patent, so that we can push this work forward toward clinical application."

POPG is one of several lipids in the fluid that lines the air sacs of the lungs. Other lipids and proteins in this surfactant fluid are known to prevent collapse of the air sacs and to contribute to innate immunity. Only recently have Dr. Voelker and his colleagues discovered POPG's anti-inflammatory function and its ability to inhibit viral infection.

"Lipids such as POPG, offer potential advantages over antiviral proteins, because they are less likely to elicit unwanted immune responses, are more chemically stable, and less expensive to manufacture than proteins," said Dr. Voelker.


'/>"/>

Contact: William Allstetter
allstetterw@njhealth.org
303-398-1002
National Jewish Health
Source:Eurekalert

Page: 1

Related biology news :

1. Felix Goñi, Avanti award for best European research in lipids
2. UI researcher learns mechanism of hearing is similar to car battery
3. Plan to turn farm waste into paper earns students $15,000
4. Louisiana Tech University professor earns national honor from Society of American Foresters
5. American Society for Microbiologys newest journal earns a high impact factor in latest rankings
6. Florida Tech biological sciences professor earns $257,000 NSF grant to study coral diseases
7. LaserLock Technologies Files for Provisional Patent Enabling Mobile Phones with Anti-Counterfeiting Technology
8. Celladon Corporation Receives Notice of Allowance from United States Patent and Trademark Office
9. Texas Biomed files patent for a novel HIV vaccine strategy
10. USDA patents method to reduce ammonia emissions
11. Aware Announces Closing Of Sale Of Selected Patents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2016)... Nov. 28, 2016 "The ... of 16.79%" The biometric system market is in ... in the near future. The biometric system market is ... 2022, at a CAGR of 16.79% between 2016 and ... of biometric technology in smartphones, rising use of biometric ...
(Date:11/22/2016)... According to the new market research report "Biometric System Market by ... Component (Hardware and Software), Function (Contact and Non-contact), Application, and Region - ... grow from USD 10.74 Billion in 2015 to reach USD 32.73 Billion ... Continue Reading ... ...
(Date:11/21/2016)... , Nov. 21, 2016   Neurotechnology , ... recognition technologies, today announced that the MegaMatcher On ... was submitted for the NIST Minutiae Interoperability ... all the mandatory steps of the evaluation protocol. ... a continuing test of fingerprint templates used to ...
Breaking Biology News(10 mins):
(Date:12/5/2016)... WOODCLIFF LAKE, N.J. , Dec. 5, 2016 ... its Phase 3 open-label two-year study of rufinamide, ... of the American Epilepsy Society (AES) held from ... . Analysis of final two-year safety, tolerability and ... therapy with rufinamide experienced similar safety and tolerability ...
(Date:12/5/2016)... The U.S. Biotechnology industry is ... of revenue and some $890 billion of total market ... biopharmaceuticals, and this figure is expected to exceed $220 ... these four equities for assessment: Northwest Biotherapeutics Inc. (NASDAQ: ... ACAD ), Acorda Therapeutics Inc. (NASDAQ: ...
(Date:12/4/2016)... ... December 03, 2016 , ... Microbial genomics leader ... grant award has been made to Dr. Renato Polimanti of Yale University School ... the oral microbiome. Grant proposals have been vetted by the company’s scientific review ...
(Date:12/4/2016)... Mass. and CAMBRIDGE, Mass. ... Africa , Dec. 4, 2016 ... providing connected diagnostics software platforms for the developing ... making "Anywhere. Care.™" a reality with its portable ... have entered into a development and license agreement ...
Breaking Biology Technology: